Search Results
Sep 04, 2026, 20:26 ET STRATEGISCH PARTNERSCHAP MET CARESTER VOOR DE ONTWIKKELING VAN OXIDESEPARATIE EN EEN 10-JARIGE AFNAMEOVEREENKOMST
Carester Realised Price en aan eventuele door de overheid vastgestelde bodemprijzen (Frankrijk/Europa, VS of Japan) voor Magnet Rare Earth Oxides ("MREO") en yttrium ("Y") die in de Caremag-faciliteit worden geproduceerd.Hoge, uiteenlopende marktprijzen: Westerse prognoses voor Dy, Tb
More news about: Lindian Resources Limited
Sep 03, 2026, 23:50 ET STRATEGISCHE PARTNERSCHAFT MIT CARESTER ZUR ENTWICKLUNG DER OXIDTRENNUNG UND 10-JAHRES-ABNAHMEVERTRAG
erzielten Preis gekoppelt und an einen etwaigen staatlich festgelegten Mindestpreis (Frankreich/Europa, USA oder Japan) für Seltenerdoxide für Magnete („MREO") und Yttrium („Y") gebunden, die in der Caremag-Anlage hergestellt werden.Hohe, stark voneinander abweichende Marktpreise:
More news about: Lindian Resources Limited
Sep 03, 2026, 23:43 ET PARTENARIAT STRATÉGIQUE AVEC CARESTER POUR LE DÉVELOPPEMENT DE LA SÉPARATION DES OXYDES ET CONTRAT D'ACHAT FERME DE 10 ANS
sur tout prix plancher fixé par les pouvoirs publics (en France/en Europe, aux États-Unis ou au Japon) pour les aimants d'oxydes de terres rares (« MREO ») et l'yttrium (« Y ») produits sur le site de Caremag.Prix du marché élevés et divergents : prévisions occidentales
More news about: Lindian Resources Limited
Sep 02, 2026, 20:49 ET STRATEGIC PARTNERSHIP WITH CARESTER FOR OXIDE SEPARATION DEVELOPMENT AND 10-YEAR OFFTAKE AGREEMENT
pricing linked to the Carester Realised Price and tied to any government floor price (France/Europe, US or Japan) provided for Magnet Rare Earth Oxides ("MREO") and yttrium ("Y") produced at the Caremag Facility.High-value, divergent market prices: Western forecasts for Dy,
More news about: Lindian Resources Limited
Sep 02, 2026, 20:08 ET STRATEGIC PARTNERSHIP WITH CARESTER FOR OXIDE SEPARATION DEVELOPMENT AND 10-YEAR OFFTAKE AGREEMENT
pricing linked to the Carester Realised Price and tied to any government floor price (France/Europe, US or Japan) provided for Magnet Rare Earth Oxides ("MREO") and yttrium ("Y") produced at the Caremag Facility.High-value, divergent market prices: Western forecasts for Dy,
More news about: Lindian Resources Limited
Aug 11, 2026, 08:00 ET Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
("Sentynl"), a U.S.-based biopharmaceutical company and wholly-owned subsidiary of Zydus Lifesciences Limited ("Zydus") and Mereo BioPharma Group plc (Nasdaq: MREO) ("Mereo" or the "Company"), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that they have entered into an option
More news about: Sentynl Therapeutics
Apr 06, 2026, 03:45 ET Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MREO during the class period listed are encouraged
More news about: DJS Law Group LLP
Apr 06, 2026, 02:32 ET MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Apr 05, 2026, 16:59 ET MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023 and December 26, 2025 (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Apr 03, 2026, 09:08 ET MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026
LLP, a leading national securities law firm, is investigating potential claims against Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Apr 02, 2026, 12:21 ET DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026
Berger Montague PC announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo" or the "Company") on behalf of investors who purchased American Depositary Shares ("ADS") issued by Mereo during the period from June
More news about: Berger Montague
Apr 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected]
More news about: Pomerantz LLP
Apr 01, 2026, 09:00 ET Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO
1, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 31, 2026, 18:37 ET MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023 and December 26, 2025 (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Mar 31, 2026, 09:00 ET MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm
March 31, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Mereo BioPharma Group plc (NASDAQ: MREO).
More news about: The Gross Law Firm
Mar 30, 2026, 03:43 ET MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 30, 2026, 03:42 ET Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Group plc ("Mereo" or "the Company") (NASDAQ: MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MREO during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 28, 2026, 10:03 ET MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
leading national securities law firm, is investigating potential claims against Mereo BioPharma Group plc ("Mereo BioPharma" or the "Company") (NASDAQ: MREO) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP
Mar 26, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO
multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-mereo-biopharma-group-plc-of-class-action-lawsuit-and-upcoming-deadlines--mreo-302725656.htmlSOURCE
More news about: Pomerantz LLP
Mar 25, 2026, 22:52 ET MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit
-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Mereo BioPharma Group plc (NASDAQ: MREO) between June 5, 2023 and December 26, 2025 (the "Class Period"), of the important April 6, 2026 lead plaintiff deadline.
More news about: THE ROSEN LAW FIRM, P. A.
Mar 25, 2026, 09:00 ET Shareholders of Mereo BioPharma Group plc Should Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights - MREO
25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Mereo BioPharma Group plc ("Mereo" or the "Company") (NASDAQ: MREO) of a class action securities lawsuit.
More news about: Levi & Korsinsky, LLP
Mar 24, 2026, 09:00 ET MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm
March 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Mereo BioPharma Group plc (NASDAQ: MREO).
More news about: The Gross Law Firm
Mar 23, 2026, 03:27 ET MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange
More news about: The Schall Law Firm
Mar 23, 2026, 03:26 ET Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
Group plc ("Mereo" or "the Company") (NASDAQ: MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of MREO during the class period listed are encouraged
More news about: DJS Law Group LLP
Mar 22, 2026, 08:52 ET MREO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
leading national securities law firm, is investigating potential claims against Mereo BioPharma Group plc ("Mereo BioPharma" or the "Company") (NASDAQ: MREO) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed
More news about: Faruqi & Faruqi, LLP